Lincoln National Corp Agenus Inc Transaction History

Lincoln National Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$0.53 - $0.93 $66 - $116	-125 Reduced 0.12%	100,475 $58,000
Q4 2023 Feb 06, 2024	BUY	$0.63 - $1.14 $12,663 - $22,913	20,100 Added 24.97%	100,600 $83,000
Q2 2023 Aug 04, 2023	BUY	$1.31 - $2.04 $6,550 - $10,200	5,000 Added 6.62%	80,500 $128,000
Q1 2023 May 01, 2023	BUY	$1.45 - $2.95 $580 - $1,180	400 Added 0.53%	75,500 $114,000
Q3 2022 Nov 03, 2022	BUY	$1.96 - $3.14 $29,400 - $47,100	15,000 Added 24.96%	75,100 $154,000
Q1 2022 May 09, 2022	BUY	$2.35 - $3.47 $23,500 - $34,700	10,000 Added 19.96%	60,100 $148,000
Q4 2021 Jan 26, 2022	BUY	$2.92 - $5.74 $292 - $574	100 Added 0.2%	50,100 $161,000
Q2 2021 Aug 13, 2021	BUY	$2.56 - $5.49 $51,200 - $109,800	20,000 Added 66.67%	50,000 $275,000
Q1 2021 May 10, 2021	BUY	$2.69 - $5.25 $13,450 - $26,250	5,000 Added 20.0%	30,000 $82,000
Q3 2020 Nov 09, 2020	BUY	$2.98 - $5.2 $74,500 - $130,000	25,000 New	25,000 $100,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.